This week in virology, the podcast about viruses, the kind that make you sick.

From ESCV, 2020, this is TWIV, this week in virology, a special episode recorded on September

8th, 2022. I'm Vincent Rackenello and you're listening to the podcast all about viruses. ESCV is the European

Society for Clinical Virology and this is their first in-person meeting in a couple of years

and we're in Manchester, England. And for this episode, my guest is professor in infectious diseases

at the University of Glasgow and the Thompson. Welcome back. Thanks very much.

Emma was on twice before 188 and 341, both recorded in Glasgow. Yep.

Have a podcast, we'll travel. And you should check those out because 188 was at the beginning of

your career, right? That's right. And 341, much later, it's talked about treatment of an Ebola

patient in Glasgow, right? That's great. Yeah. And so today we're going to talk about pediatric hepatitis.

But before that, remind us about your training where you did what before you got here.

I studied in Glasgow and I studied medicine at Glasgow University and then also parasitology,

actually. And then I went to London where I trained in infectious diseases and then at a PhD

between London and Oxford University with Paul Klanerman and with John Weber, my own clerk.

And Peter Cariannis on hepatitis C, so that's my background, but we've kind of moved a bit away

from that now. And then I moved back to Glasgow around about 10 years ago to the MRC University

of Glasgow Centre for Fires Research. I remember you did a lot of hep C work.

I assume today you're doing a lot of SARS-CoV-2 and now the pediatric hepatitis,

any more hep C going on in your lab. We're still looking at hep C particularly in sub-Saharan Africa.

We've been describing some more divergent genotypes in sub-Saharan Africa, which are not

still not fully characterized and still we don't know enough about how well they respond to

treatments, although the studies that we've been doing are largely reassuring, which is great.

...